CrossrefInfokarte
Comparative efficacy of biosimilar denosumab and reference denosumab in treatment of postmenopausal osteoporosis: a systematic review and meta-analysis
Osteoporosis International · 2026-10 · 37 (10) · 2605-2615
DOI: 10.1007/s00198-026-08159-3 ↗Abstract
Kein Abstract verfügbar.
EUVIMED